DI-UMONS : Dépôt institutionnel de l’université de Mons

Recherche transversale
(titres de publication, de périodique et noms de colloque inclus)
2017-07-23 - Colloque/Abstract - Anglais - 1 page(s) (Soumise)

Macoir J., Fossard M., Lefebvre Laurent , Monetta L., Renard A., Tran T.-M., Wilson M., "DTLA-A New Screening Test for Language Impairment in Aging." in IAGG 2017 World Congress of Gerontology and Geriatrics-July, 23-27. , San Francisco, US, 2017

  • Codes CREF : Psychopathologie (DI3513), Neurosciences cognitives (DI4296), Sciences cognitives (DI4290), Psychologie cognitive (DI4211)
  • Unités de recherche UMONS : Psychologie cognitive et Neuropsychologie (P325)
  • Instituts UMONS : Institut de recherche en sciences et technologies du langage (Langage), Institut des Sciences et Technologies de la Santé (Santé)
  • Centres UMONS : Mind & Health (CREMH)
Texte intégral :

Abstract(s) :

(Anglais) IAGG 2017 World Congress - San Francisco - July, 2017. Title (max 100 characters) DTLA – A New Screening Test for Language Impairment in Aging Authors Joël Macoir, Marion Fossard, Laurent Lefebvre, Laura Monetta, Antoine Renard, Thi Mai Tran, Maximiliano A. Wilson. Abstract (250 words) Compared to cognitive functions such as working memory and executive functions, language appeared to be mostly resistant to age-related decline. However, language is affected in the early stages of major forms of dementia and, language deficits are at the core of the clinical portrait of primary progressive aphasia. Primary care providers are frequently faced with patients whose main complaints concern language problems in everyday and professional life. Up to now, no brief, accurate, screening test, which could be applied during routine office visits, is available for language deficits in neurodegenerative diseases. The aim of this study was to fill this important lack by developing a handy, sensitive and brief detection test for language impairments in adults and aging. In this presentation, we describe the psychometric properties of the DTLA (Detection Test for Language impairments in Adults and Aging), a new screening test developed in four French-speaking countries (Belgium, Canada, France, Switzerland). We first present the development phase of the DTLA, then we provide normative data for healthy, community-dwelling, French-speaking people from the four countries and finally, we report data on the convergent and discriminant validity of the DTLA as well as on its test-retest and internal consistency reliability. The use of the DTLA could improve the diagnosis of neurodegenerative diseases, especially those in which language is primarily affected. Ultimately, this will permit patients and their families to receive services at an earlier stage of the disease. Objective 1. After attending this presentation, participants will be informed about language impairment in neurodegenerative diseases. Objective 2. After attending this presentation, participants will be informed about the assessment of language in pathological aging and the clinical utility of the DTLA.